The main differentiating factor turns out to be organizational effectiveness: the way that the R&D organization creates a context that encourages cooperative behavior among its staff. A promising approach in this regard is to pursue smart simplicity, a potent new system for managing the complexity of modern organizations and turning it to advantage.
The case of Bristol-Myers Squibb Company is instructive. Already one of the outperformers, the company has developed a program that further enhances cooperative behavior among its workforce. R&D leaders at other companies can draw valuable lessons from the case, though they will, of course, have to take their company’s own unique circumstances into account.
Enjoy curated articles directly to your inbox.